A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 1,112,491 shares of NVS stock, worth $123 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
1,112,491
Previous 845,001 31.66%
Holding current value
$123 Million
Previous $81.7 Million 44.9%
% of portfolio
0.38%
Previous 0.27%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$92.57 - $107.37 $24.8 Million - $28.7 Million
267,490 Added 31.66%
1,112,491 $118 Million
Q1 2024

May 03, 2024

BUY
$95.27 - $108.47 $2.78 Million - $3.17 Million
29,197 Added 3.58%
845,001 $81.7 Million
Q4 2023

Jan 24, 2024

BUY
$92.27 - $101.54 $7.65 Million - $8.42 Million
82,909 Added 11.31%
815,804 $82.4 Million
Q3 2023

Oct 23, 2023

BUY
$94.73 - $105.13 $214,752 - $238,329
2,267 Added 0.31%
732,895 $74.7 Million
Q2 2023

Jul 25, 2023

BUY
$92.52 - $104.91 $3.87 Million - $4.39 Million
41,822 Added 6.07%
730,628 $73.7 Million
Q1 2023

May 17, 2023

BUY
$80.03 - $92.81 $55.1 Million - $63.9 Million
688,806 New
688,806 $63.4 Million
Q4 2022

Feb 09, 2023

SELL
$75.55 - $92.52 $15.7 Million - $19.2 Million
-207,397 Reduced 17.76%
960,068 $87.1 Million
Q3 2022

Nov 04, 2022

BUY
$74.61 - $87.26 $8.48 Million - $9.92 Million
113,674 Added 10.79%
1,167,465 $88.7 Million
Q2 2022

Aug 10, 2022

BUY
$80.52 - $93.75 $22.8 Million - $26.5 Million
283,045 Added 36.72%
1,053,791 $89.1 Million
Q1 2022

Apr 27, 2022

SELL
$80.11 - $90.62 $1.03 Million - $1.17 Million
-12,890 Reduced 1.64%
770,746 $67.6 Million
Q4 2021

Jan 31, 2022

BUY
$79.7 - $88.13 $1.05 Million - $1.16 Million
13,175 Added 1.71%
783,636 $68.5 Million
Q3 2021

Oct 20, 2021

SELL
$81.78 - $95.14 $11.6 Million - $13.4 Million
-141,234 Reduced 15.49%
770,461 $63 Million
Q2 2021

Jul 20, 2021

BUY
$85.24 - $94.15 $3.8 Million - $4.2 Million
44,601 Added 5.14%
911,695 $83.2 Million
Q1 2021

Apr 22, 2021

BUY
$83.5 - $98.47 $2.41 Million - $2.84 Million
28,827 Added 3.44%
867,094 $74.1 Million
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $1.27 Million - $1.54 Million
-16,328 Reduced 1.91%
838,267 $79.2 Million
Q3 2020

Nov 06, 2020

SELL
$82.14 - $91.0 $1.97 Million - $2.18 Million
-24,007 Reduced 2.73%
854,595 $74.3 Million
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $2.38 Million - $2.68 Million
29,458 Added 3.47%
878,602 $76.7 Million
Q1 2020

May 13, 2020

SELL
$70.67 - $99.01 $432,359 - $605,743
-6,118 Reduced 0.72%
849,144 $70 Million
Q4 2019

Feb 12, 2020

BUY
$84.35 - $95.37 $2.93 Million - $3.32 Million
34,790 Added 4.24%
855,262 $81 Million
Q3 2019

Nov 20, 2019

BUY
$85.54 - $94.26 $4.99 Million - $5.5 Million
58,324 Added 7.65%
820,472 $71.3 Million
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $3.05 Million - $3.75 Million
40,397 Added 5.6%
762,148 $69.6 Million
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $10.1 Million - $11.5 Million
133,909 Added 22.78%
721,751 $59.4 Million
Q4 2018

Feb 14, 2019

BUY
$73.66 - $82.02 $6.76 Million - $7.52 Million
91,739 Added 18.49%
587,842 $50.4 Million
Q3 2018

Oct 23, 2018

BUY
$66.94 - $77.43 $1.68 Million - $1.95 Million
25,121 Added 5.33%
496,103 $42.7 Million
Q2 2018

Aug 02, 2018

BUY
$64.91 - $73.36 $526,679 - $595,243
8,114 Added 1.75%
470,982 $35.6 Million
Q1 2018

Apr 10, 2018

BUY
$70.39 - $84.15 $3.07 Million - $3.67 Million
43,670 Added 10.42%
462,868 $37.4 Million
Q4 2017

Jan 22, 2018

BUY
$72.33 - $77.64 $3.51 Million - $3.77 Million
48,577 Added 13.11%
419,198 $35.2 Million
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $27.5 Million - $28.6 Million
370,621
370,621 $31.8 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.